Shimadzu-CGH Clinomics Centre

The Shimadzu-CGH Clinomics Centre (SC³) is Singapore's specialist clinical mass spectrometry centre dedicated to precision diagnostics, translational research, and laboratory innovation. Established through a strategic partnership between Changi General Hospital (CGH) and Shimadzu (Asia Pacific), SC³ integrates advanced analytical technologies with clinical expertise to enhance diagnosis, treatment planning and patient care.

As a regional centre of excellence, SC³ develops and delivers highly specialised laboratory tests for conditions and areas such as endocrine disorders, hypertension, therapeutic drug monitoring and emerging biomarkers. Beyond clinical diagnostic services, SC³ partners with clinicians, researchers and industry to translate scientific discoveries into clinically validated diagnostic solutions.

SC³ brings together clinical and research expertise, laboratory innovations and clinical care, enabling precision medicine through reliable laboratory diagnostics underpinned by established quality processes.